ACASTI PHARMA
Acasti Pharma is an emerging biopharmaceutical company dedicated to the research, development, and commercialization of innovative proprietary active pharmaceutical ingredients (API) for the management of cardiometabolic disorders, from prevention to treatment, through a novel superior approach to lipid regulation.
ACASTI PHARMA
Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics
Founded:
2002-01-01
Address:
Laval, Quebec, Canada
Country:
Canada
Website Url:
http://www.acastipharma.com
Total Employee:
11+
Status:
Active
Contact:
450-686-4555
Email Addresses:
[email protected]
Total Funding:
54.88 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache
Similar Organizations
Aurealis Pharma
Aurealis Pharma is a biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-05-07 | Grace Therapeutics | Grace Therapeutics acquired by Acasti Pharma | 64 M USD |
Official Site Inspections
http://www.acastipharma.com Semrush global rank: 6.91 M Semrush visits lastest month: 701
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Acasti Pharma" on Search Engine
Company Information :: Acasti Pharma Inc. (ACST)
Acasti is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Acasti's novel technologies have the potential to improve the performance of …See details»
Management Team :: Acasti Pharma Inc. (ACST)
Prashant Kohli has served as the Corporation’s Chief Executive Officer since April 2023. He has over 20 years of commercialization experience leading strategy, sales, marketing, …See details»
Board of Directors :: Acasti Pharma Inc. (ACST)
Prashant Kohli. Chief Executive Officer and Director. Prashant Kohli has served as the Corporation’s Chief Executive Officer since April 2023. He has over 20 years of …See details»
Acasti Pharma - Crunchbase Company Profile & Funding
Acasti Pharma is an emerging biopharmaceutical company dedicated to the research, development, and commercialization of innovative proprietary active pharmaceutical …See details»
Acasti Pharma to Present at Q4 Investor Summit
LAVAL, Québec, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma …See details»
Acasti Pharma Reports Fiscal Year 2022 Operational Results
Company to Host Conference Call Today at 1:00pm ET. LAVAL, Québec, June 21, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: …See details»
Acasti Pharma Inc. | LinkedIn
Acasti is a late-stage specialty pharma company with drug delivery capability and technologies addressing rare and orphan diseases.See details»
Acasti Pharma Announces Successful Completion of its Merger …
LAVAL, Québec, Aug. 27, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti”) (NASDAQ: ACST–TSX-V: ACST), announced today the completion of its previously …See details»
Acasti Announces Voting Results from 2022 Annual and Special …
LAVAL, Québec, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST and TSX-V: ACST), a late-stage, specialty pharma …See details»
Acasti Pharma Reports Fiscal Year 2023 Operational Results
Jun 23, 2023 Acasti Pharma Inc. ("Acasti" or the "Company") (Nasdaq: ACST), a late-stage, biopharma company advancing GTX-104, its novel formulation of nimodipine that …See details»
Acasti Pharma Announces Successful Completion of its Merger …
Fri, Aug 27, 2021, 8:40 AM 8 min read. In this article: ACST. LAVAL, Québec, Aug. 27, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“ Acasti ”) (NASDAQ: ACST–TSX-V: …See details»
Press Releases :: Acasti Pharma Inc. (ACST)
Acasti is a late-stage specialty pharma company with drug delivery capability and technologies addressing rare and orphan diseases. The Company’s novel drug delivery …See details»
Acasti Pharma Inc. (ACST) - Yahoo Finance
Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate …See details»
Acasti Pharma - Funding, Financials, Valuation & Investors
Acasti Pharma has raised a total of. $95M. in funding over 8 rounds. Their latest funding was raised on Sep 26, 2023 from a Post-IPO Equity round. Acasti Pharma is registered …See details»
Acasti Pharma to Participate in the Lytham Partners Fall 2022 …
LAVAL, Québec, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma …See details»
Org Chart Acasti Pharma - The Official Board
Org Chart Acasti Pharma - The Official Board. Acasti Pharma. has 8 executives - and belongs to Neptune Wellness Solutions. +1 450 686 4555. Add an executive. Acasti …See details»
Acasti Announces WuXi Clinical as CRO to Conduct STRIVE-ON …
Jul 10, 2023 Acasti Pharma Inc. (Nasdaq: ACST) ("Acasti" or the "Company"), a late-stage, biopharma company advancing GTX-104, today announced WuXi Clinical …See details»
Acasti Pharma Announces Annual Grants of Performance Stock …
Jun 22, 2022 Acasti Contact: Jan D’Alvise Chief Executive Officer Tel: 450-686-4555 Email: [email protected] www.acastipharma.com. Investors: Robert Blum Lytham …See details»
Acasti Pharma - Contacts, Employees, Board Members, Advisors …
Organization. Acasti Pharma. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Employee Profiles 6. Number of Board …See details»